Back to search

Article

Recombinant dimeric PDZ protein inhibitors for long-term relief of chronic pain by AAV therapeutics

2023-03-03

Abstract excerpt

<h4>ABSTRACT</h4> The inadequate state of current pain treatments, the chronic nature of particularly neuropathic pain, and the high impact on quality of life render chronic pain conditions relevant for gene therapy. Here, we describe the development and application of self-assembling dimeric peptide inhibitors of the pain-associated scaffolding protein PICK1 (protein interacting with C-kinase 1) delivered by ade...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cadb1c9e-4f90-5585-9296-733f9b100c43
DOI
10.1101/2023.03.03.530962
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Recombinant dimeric PDZ protein inhibitors for long-term relief of chronic pain by AAV therapeuticsDOI 10.1101/2023.03.03.530962
Select a neighboring publication to make it the new centre.